Retina Specialists at Lurie Children’s Perform Illinois’ First Gene Therapy Eye Surgery with LUXTURNA(r)

The Division of Ophthalmology at Ann & Robert H. Lurie Children’s Hospital of Chicago recently became an Ocular Gene Therapy Treatment Center for LUXTURNA(r) (voretigene neparvovec-rzl), the first gene therapy approved in the U.S. to treat children and adult patients with a form of vision loss that can result in blindness. 

Read More